The U.S. Food and Drug Administration said on Tuesday it has approved SpringWorks Therapeutics' drug to treat a type of rare ...

Aerospace startup Boom says they've proven quiet supersonic flight is possible with their passenger airplanes after a ...

We recently published a list of 10 Safest Dividend Stocks in the UK. In this article, we are going to take a look at where ...

Shares of AstraZeneca Pharma India Ltd closed at ₹7,450 on the BSE, down 1.29% ahead of the earnings announcement.

As per the reported property consultants, the company has issued a global mandate for selecting candidates for the said land ...

Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment.

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Decision puts spotlight on Lord Hermer, who represented the former Sinn Fein leader in a separate compensation case ...

With the rising incidence of cancer in India, AstraZeneca India's breast cancer medicine trastuzumab deruxtecan (sold under ...

ACD/Labs recently released their 2025 Structure Elucidation & Verification Report, discussing how informatics trends have ...

Dr. Tycel Phillips discusses the implications of the FDA approval of Calquence plus bendamustine and Rituxan in untreated MCL ...

Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.